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Background: Tremor is the most prevalent movement disorder in clinical practice. It is
defined as involuntary, rhythmic, oscillatory movements.The diagnostic process of patients
with tremor can be laborious and challenging, and a clear, systematic overview of avail-
able diagnostic techniques is lacking. Tremor can be a symptom of many diseases, but
can also represent a distinct disease entity. Objective: The objective of this review is to
give a clear, systematic and step-wise overview of the diagnostic work-up of a patient with
tremor.The clinical relevance and value of available laboratory tests in patients with tremor
will be explored. Methods: We systematically searched through EMBASE. The retrieved
articles were supplemented by articles containing relevant data or provided important back-
ground information. Studies that were included investigated the value and/or usability of
diagnostic tests for tremor. Results: In most patients, history and clinical examination by
an experienced movement disorders neurologist are sufficient to establish a correct diag-
nosis, and further ancillary examinations will not be needed. Ancillary investigation should
always be guided by tremor type(s) present and other associated signs and symptoms.The
main ancillary examination techniques currently are electromyography and SPECT imag-
ing. Unfortunately, many techniques have not been studied in large prospective, diagnostic
studies to be able to determine important variables like sensitivity and specificity. Conclu-
sion: When encountering a patient with tremor, history, and careful clinical examination
should guide the diagnostic process. Adherence to the diagnostic work-up provided in this
review will help the diagnostic process of these patients.
Keywords: tremor, essential tremor, diagnosis, electromyography, differential diagnosis, action tremor
INTRODUCTION
Tremor is defined as rhythmic, oscillatory involuntary movements
(Deuschl et al., 1998). It is a common symptom of a wide range
of neurological and other disorders, as well as a disease entity
in itself. The diagnostic process of patients with tremor can be
laborious and difficult. For example, 30 to even 50% of patients
with essential tremor are misdiagnosed (Jain et al., 2006). Some-
times, effective specific treatment fails or is delayed due to limited
diagnostic tools. Even if treatment is successful, the therapeutic
process could take months, involving different drugs, with the con-
sequence of unnecessary side-effects of medication. This process
can also be costly, since wrong diagnostic tests and wrong types of
medication may be used. The objective of this review is to provide
a clinical practice guideline with respect to diagnosing tremor dis-
orders. Different types of tremor, their typical clinical features and
underlying pathophysiology are summarized. A systematic litera-
ture search has been performed on the diagnostic use of ancillary
examinations in the light of differentiating tremor syndromes.
Finally, we propose a flow chart on how to approach a patient
presenting with tremor.
METHODS
We searched EMBASE for identifying all articles on diag-
nostic techniques in tremor using the following search:
(exp tremor/OR tremor$.tw.) AND [exp electromyography
(EMG)/OR electromyograph∗.tw. OR EMG.ti,ab. OR (tremor
adj2 registration).tw. OR accelerometer/or accelerometry/OR
exp electroencephalography/OR EEG.ti,ab. OR electromyo-
graph$.ti,ab. OR ioflupane i 123/OR datscan.mp. OR exp nuclear
magnetic resonance imaging (MRI)/OR (magnetic adj reso-
nance).ti,ab. OR MRI.ti,ab.] AND (exp diagnosis/OR di.fs. OR
diagnos∗.ti,ab) NOT (“review”/OR case report/) NOT (ani-
mal/not human/). This search specifically looked for studies on
EMG, accelerometry, electroencephalography, [123I]-FP-CIT sin-
gle photon emission computerized tomography, and MRI. Fur-
thermore, the search included studies on tremor in combination
with “diagnosis.”
The search retrieved 2114 citations. Reviews, case-reports, ani-
mal studies, studies on therapy or studies on pathophysiology were
excluded, leaving a remaining 425 articles, 40 of these articles were
included in this review, because these studies investigated the value
and/or usability of a certain diagnostic test for clinical practice in
patients with tremor and were available in English. The 40 arti-
cles included in this review were supplemented by an additional
49 articles. These articles were identified as containing relevant
data while reviewing references cited in the retrieved articles, or
provided important background information.
RESULTS
CLASSIFICATION OF TREMOR
Tremor can be present during rest (rest/resting tremor), or during
voluntary contraction of muscles (action tremor; Table 1). Action
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Table 1 |Types of tremor.
Subtype Occurrence Physical examination
TYPES OFTREMOR
Rest tremor Rest/resting tremor In a body part that is not voluntarily activated and
completely supported against gravity
Letting forearms rest on legs or armrest, flexed
elbows, with palms in a supinated position
Action tremor Postural tremor During voluntarily maintaining a position against
gravity
Keep arms and fingers in stretched and flexed
positions
Simple kinetic tremor During non-target-directed movements E.g., finger tapping
Intention tremor During visually guided movements toward a target at
the endpoint of a movement
E.g., finger-to-nose test
Task-specific kinetic tremor During a specific skilled task Specific and aspecific tasks
Isometric tremor During isometric muscle contraction E.g., contraction against a static object, making
a fist
Isometric orthostatic tremor During stance or stance phase of walking Standing, walking
tremor can be further divided into several subtypes, summarized
in Table 1 (Deuschl et al., 1998). Tremor can also be categorized
by frequency. Three frequency domains have been appointed: (1)
low frequency tremors with a frequency below 4 Hz, (2) middle
frequency tremor between 4 and 7 Hz, and (3), tremors with a
high-frequency above 7 Hz (Deuschl et al., 1998).
THE PATIENT WITH TREMOR
The prevalence of a specific tremor disorder defines the prior prob-
ability of encountering a patient with that tremor disorder. Every
tremor disorder has certain characteristics that can help to differ-
entiate from other tremor disorders, such as age at onset, sequence
of spread, sudden, or gradual onset and the body part(s) first
affected (Bain, 2007). For an overview of most common tremor
disorders, see Table 2.
Essential tremor is the most common form of tremor, with an
estimated prevalence between 0.4 and 0.9% in the general popula-
tion, and an increase with age, with a prevalence of up to 4.6% in
people over 65 years old, and even 22% in people over 95 years old
(Louis and Ferreira, 2010). The mean age at onset of ET is around
45 years, but tremor can also present itself in early adulthood and
even during childhood. The incidence increases with advancing
age. Usually, patients do not seek medical attention until more
advanced age because of its slowly progressive nature. Symmetri-
cal postural and/or intention tremor between 4 and 12 Hz in the
arms without any other neurological signs is most suggestive for
ET (Deuschl et al., 1998). Tremor in many ET patients attenuates
upon alcohol intake (Koller and Biary, 1984). See Table 3 for the
diagnostic criteria of ET and the differential diagnosis of middle
frequency postural tremor. It has been suggested that intention
tremor is more severe than postural tremor, which may even be
absent (Brennan et al., 2002). Upper limbs are affected in about
95% of patients, followed by head (34%), lower limbs (20%), voice
(12%), face and trunk (5%; Elble, 2000). Rest tremor is present in
about 18% of ET patients (Cohen et al., 2003). Task-related dis-
ability, such as difficulties with eating and drinking, is indicative
for ET. In some cases, ET patients show an autosomal dominant
inheritance pattern, with a positive family history ranging from
17 to 100% of the cases, depending on the study (Deng et al.,
2007).
When a 4- to 9-Hz resting tremor, or “pill-rolling” tremor,
typical for Parkinson’s disease (PD) is present, attention should
be directed to the presence of rigidity and bradykinesia. The
prevalence is roughly estimated to be about 0.3% of the general
population, and increases up to 1% in people at the age of 60 (de
Lau and Breteler, 2006). Rest tremor in PD usually starts after the
age of 60 and progresses gradually. Typical for rest tremor in PD is
re-emerging tremor: tremor that is present during rest, disappears
upon stretching of the arms, and “re-emerges” when the arms are
maintained in the same position. Postural tremor is present in up
to 60% of PD patients, and can have a higher tremor frequency
(>1.5 Hz) then the rest tremor (Bain, 2007). Cog wheeling can be a
phenomenon of both ET and PD, because it appears to be related
to the presence of tremor rather than to rigidity (Louis, 2011).
For this reason it should not be considered as a differential sign
between ET and PD. While a positive response to alcohol intake is
in line with the diagnosis of ET, alcohol has no effect on tremor in
PD (Koller and Biary, 1984; Lakie et al., 1994; Bain, 2011).
Enhanced physiologic tremor is a high-frequency (8–12 Hz),
low-amplitude, mostly postural, bilateral tremor. Drugs and tox-
ins, such as caffeine, induce this form of tremor. Also, tremor inten-
sifies with anxiety, stress, and after strenuous exercise. Enhanced
physiologic tremor does not interfere with daily activities, in
contrast to ET. Intention tremor is not typical for enhanced
physiologic tremor (Deuschl et al., 1998).
Dystonic posturing in the same body part suggests a dystonic
tremor, for example cervical dystonia and head tremor. When the
trembling body part is not affected by dystonia, but dystonic pos-
turing occurs in other body parts, this is referred to as “tremor
associated with dystonia” (Deuschl et al., 1998). Whether this last
group should be classified as ET with dystonia or as a “tremulous
dystonia syndrome” remains controversial (Schiebler et al., 2011).
Usually dystonic tremor increases in amplitude when moving in
opposition to the direction of dystonic contractions and tends to
show much greater right–left asymmetry than essential tremor
(LeDoux, 2012). Some patients have a trick to alleviate tremor, a
so-called “sensory trick”. This can be a sign of dystonia (Masuhr
et al., 2000). Dystonic tremor occurs usually in patients younger
than 50 years. In patients with arm tremor including a resting
tremor and reduced arm swing on the affected side, it can be
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Table 2 | Most common tremor disorders.
Diagnosis Tremor type(s) Frequency
range
Accompanying features Pathophysiology
MOST COMMONTREMOR DISORDERS
Enhanced
physiologic
tremor
Posture 5–12 Hz Increases after caffeine intake, and upon
stress and anxiety
Consists of two distinct oscillations, a
mechanical-reflex oscillations and a
central-neurogenic oscillation (Elble, 1996)
Essential tremor Posture
intention rest
4–12 Hz Additional or isolated head tremor
(Critchley, 1949), tandem gait
abnormalities (Stolze et al., 2001)
Involvement of parts of the
cerebello-thalamo-cortical network (Louis,
2011)
Parkinsonian
tremor
Rest posture
intention
4–9 Hz Bradykinesia, rigidity, postural problems Degeneration of dopaminergic pathways
(Kraus et al., 2006)
Dystonic tremor Posture
intention rest
4–10 Hz “Gestes antagonistes,” dystonic posturing
of other body parts (Deuschl et al., 1998)
Unknown, but can be related to basal ganglia
dysfunction observed in dystonia
(Pont-Sunyer et al., 2012)
Psychogenic
tremor
Rest posture
intention
4–12 Hz Entrainment, increase in tremor amplitude
with loading, inconsistent over time
(Edwards and Schrag, 2011)
Unknown (Edwards and Schrag, 2011)
Toxic and
drug-induced
tremor
Posture
intention rest
3–12 Hz Medication/drug use, exposure to heavy
metals, symptoms of metabolic disorders
(Puschmann and Wszolek, 2011)
Various mechanisms (Morgan and Sethi,
2005)
Cerebellar
tremor
Intention 2–5 Hz Eye-movement abnormalities, dysmetria,
dyssynergia, trunk titubation (Degardin
et al., 2012)
Lesions of the lateral cerebellar nuclei, the
superior cerebellar peduncle, or the
pathways where they are involved
(Pont-Sunyer et al., 2012)
Task-specific
tremor
Posture
intention
4–8 Hz Occurs during specific task (i.e., writing;
Bain, 2011)
May be related to essential tremor or
dystonia (writer’s cramp; Bain, 2011)
Holmes’ tremor Rest intention
posture
2–5 Hz Evidence of lesions of the central nervous
system (Deuschl et al., 1998), neurological
signs associated with lesions
Lesions in the dopaminergic nigrostriatal and
cerebello-thalamic pathways (Seidel et al.,
2009)
Cortical
myoclonic tremor
Posture
intention
6–20 Hz (Family) history of epileptic seizures (van
Rootselaar et al., 2006)
GABAA-ergic dysfunction within the cerebral
cortex (van Rootselaar et al., 2007)
Neuropathic
tremor
Posture 4–12 Hz Muscle weakness, absent reflexes,
glove/stocking sensory deficits
(Pont-Sunyer et al., 2012)
Slow nerve conduction increases the delay
of a stretch reflex response, leading to
enhancement of the tremor, but central
components can also be involved
(Pont-Sunyer et al., 2012)
An overview of most common tremor disorders. The tremor type(s) and frequency range columns are adapted from the MDS consensus statement (Deuschl et al.,
1998).
difficult to differentiate between PD and dystonia at an early stage
(Schneider et al., 2007). In these cases, attention should be given
to other clinical signs of PD or dystonia. Response to levodopa
treatment is highly suggestive of PD (D’Costa et al., 1991).
Systemic signs of hyperthyroidism, such as excessive sweating,
palpitations, and weight loss, should be checked, since hyper-
thyroidism can cause a low-amplitude, middle-to-high-frequency
postural tremor (Milanov and Sheinkova, 2000). Other meta-
bolic disorders that can cause tremor include renal failure,
hypoglycemia, and liver disease (Pont-Sunyer et al., 2012).
In addition to previously mentioned tremor disorders, there
are many other, less prevalent, tremor syndromes, some of which
should not be missed because they might be treatable (see Table 4
for alarm symptoms in tremor patients). In patients before the
age of 40 presenting with tremor, concerns should be raised
for Wilson disease, an autosomal recessive inherited disorder in
copper-metabolism (Roberts and Schilsky, 2008). Tremor in Wil-
son disease is often postural, starts in one limb, and may eventually
spread to the whole body.“Wing beating tremor”is one of the char-
acteristic symptoms of Wilson disease and consists of a proximal
tremor of high amplitude, best seen when the patients stretches the
arms (Roberts and Schilsky,2008; Puschmann and Wszolek,2011).
Patients suspected of having Wilson disease, should be examined
for Kayser–Fleischer rings and hepatosplenomegaly (Roberts and
Schilsky, 2008). Ancillary examination up to 55 years of age is
necessary to exclude or confirm Wilson disease (see Ancillary
Examinations) and neuroimaging is indicated in all patients with
Wilson disease presenting with neurological symptoms. Wilson
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Table 3 | Clinical criteria for ET and differential diagnosis for a patient with middle frequency postural tremor.
Clinical criteria for ET (MDS consensus statement Deuschl et al., 1998): Differential diagnosis middle frequency postural tremor:
Inclusion criteria Essential tremor
Bilateral, largely symmetric postural, or kinetic tremor involving hands and
forearms that is visible and persistent
Parkinson’s disease
Additional or isolated tremor in head but absence of abnormal posturing Enhanced physiologic tremor
Exclusion criteria Dystonic tremor
Other abnormal neurological signs (especially dystonia) Wilson disease
Presence of known causes of enhanced physiologic tremor Primary writing tremor
Historical or clinical evidence of psychogenic tremor Epilepsia partialis continua
Convincing evidence of sudden onset or step-wise deterioration Familial cortical tremor
Primary orthostatic tremor Spinal segmental myoclonus
Isolated voice, tongue, chin, leg tremor Progressive myoclonic ataxia
Isolated position- or task-specific tremor Spinocerebellar ataxias
Neuropathic tremor
Drug-induced tremor
Metabolic alterations
Fragile-X-associated tremor/ataxia syndrome (FXTAS)
Table 4 | Red flags in patients with tremor.
Red flags in patients with tremor
Unexplained tremor in patient younger than 55
One-sided tremor (not PD)
Sudden onset
Start/change of medication
Other unexplained symptoms
disease is not excluded in individuals over 40 years of age, and fur-
ther evaluation should be carried out when symptoms of Wilson
disease are present (Roberts and Schilsky, 2008).
Many types of medication and life-style drugs are known to
cause or exacerbate tremor, and therefore, a detailed history of
medication use is crucial. The temporal relation of the tremor
to the start of medication and the dose-response relationship
between increasing the dosage and a simultaneous increase of
the tremor should be clarified. Table 5 provides an overview of
drugs often involved with action tremor (Morgan and Sethi, 2005).
In most instances, drug-induced tremor reduces or even abates
after removal of the agent (Morgan and Sethi, 2005). Occupa-
tional exposure to heavy metals, such as lead, manganese, and
mercury, can induce action and rest tremor. In some patients,
tremor remains after withdrawal of heavy metal contact (Urban
et al., 1996; Milanov and Kolev, 2001; Bose-O’Reilly et al., 2010).
Patient should finally be screened for alcohol abuse, since alcohol
overuse and withdrawal can cause tremor.
A prominent intention tremor in the presence of eye-
movement abnormalities, the presence of only an intention
tremor, dysmetria, dyssynergia, trunk titubation, postural abnor-
malities, or hypotonia all suggest a cerebellar tremor (Degardin
et al., 2012). Causes for cerebellar tremor include Friedreich’s
ataxia, spinocerebellar ataxia syndromes, cerebellar infarction,
multiple sclerosis, and Langerhans cell histiocytosis (Wnorowski
et al., 2008; Perlman, 2011; Shneyder et al., 2011). In cerebellar
tremor, different from ET, the tremor can even worsen after alcohol
intake.
The differential diagnosis of tremor with atypical characteris-
tics, such as an abrupt start and/or stop of tremor and tremor
that lateralizes to one side, contains psychogenic tremor and
intracranial tumors. Fluctuation in tremor during examination,
an increase of tremor upon attention, decrease of tremor upon
distraction, and entrainment of tremor to the frequency of repet-
itive movements all point toward psychogenic tremor, although
the clinical characterization remains challenging (Edwards and
Schrag, 2011; Schwingenschuh et al., 2011). Psychogenic tremor
can occur in all positions, something not often seen in organic
tremors. A useful test for discriminating psychogenic tremor from
ET is distractibility (for example serial subtraction of 7 from 100
(sensitivity 72.7% specificity 73.3%) and tapping different fin-
gers on to their thumbs in sequence (sensitivity 58.3%, specificity
84.4% Edwards and Schrag, 2011)). Contralateral tapping while
stretching the affected limb is also a useful distraction task (Spiegel
et al., 1998).
Some rare tremor disorders are associated with other signs,
which can aid the diagnosis. A positive family history for early
cognitive or neuropsychiatric deficits in males could suggest a
diagnosis of fragile X-associated tremor/ataxia syndrome, a rare
X-linked conditions characterized by ataxia and intellectual dis-
ability, where tremor and ataxia can manifest during middle age
(Berry-Kravis et al., 2007). Cognitive problems are not always
present during the development of tremor and can occur later in
the disease (Brunberg et al., 2002). Tremor in fragile X-associated
tremor/ataxia syndrome can be easily misdiagnosed as ET.
Neuropathic tremor occurs in association with peripheral neu-
ropathies. Most frequent neuropathies associated with tremors
are immune-mediated demyelinating and hereditary peripheral
neuropathies. Often there are additional neurological symptoms
present in these patients, mainly muscle weakness and sensory
deficits (Pont-Sunyer et al., 2012). Characteristically, these patients
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Table 5 | Drugs related to postural and intention tremor.
Drug group Postural tremor Intention tremor
DRUGS RELATEDTO POSTURAL AND INTENTIONTREMOR
Antiarrhythmics Amiodarone, mexiletine, procainamide –
Antibiotics, antivirals, antimycotics – Vidarabine
Antidepressants and mood stabilizers Amitriptyline, lithium, SSRIs Lithium
Antiepileptics Valproic acid –
Bronchodilators Salbutamol, salmeterol Salbutamol, salmeterol
Chemotherapeutics Tamoxifen, cytarabine, ifosfamide Cytarabine, ifosfamide
Drugs of misuse Cocaine, ethanol, MDMA, nicotine Ethanol
Gastrointestinal drugs Metoclopramide, cimetidine –
Hormones Thyroxine, calcitonin, medroxyprogesterone Epiphrine
Immunosuppressants Tacrolimus, ciclosporin, interferon-alfa Tacrolimus, ciclosporin
Methylxanthines Theophylline, caffeine –
Neuroleptics and dopamine depleters Haloperidol, thioridazine, cinnarizine, reserpine, tetrabenazine –
Drugs known to cause postural and intention tremor (Morgan and Sethi, 2005).
present with action tremor, but rest tremor also occurs (Bain,
2007).
In patients with a (family) history of epileptic seizures, famil-
ial cortical myoclonic tremor has to be suspected. These patients
may describe their tremor as shivering-like twitching of the fingers
and hands (van Rootselaar et al., 2005). These movements occur
mainly during posture and can also easily be misinterpreted as ET.
Tremor in familial cortical tremor is in fact not a real “tremor”,
but myoclonus mimicking tremor. Tremor recordings show a high
burst frequency (up to 20 Hz) (van Rootselaar et al., 2005). Also,
epilepsia partialis continua can give seemingly regular contrac-
tions in the hand, which can be confused with ET (Bien and Elger,
2008).
Finally, two tremor disorders are distinguished from other dis-
orders by their frequency. Occurrence of a high-frequency tremor
(>13 Hz) in the lower limbs that occurs or increases upon stand-
ing is suggestive of orthostatic tremor and is absent during rest.
Patients usually complain of a feeling of unsteadiness during stance
relieved by walking and sitting down, and do not mention tremor.
With a stethoscope, the fast beating “helicopter sign” can often
be heard (Gerschlager and Brown, 2011). A very low frequency
tremor during rest (<4.5 Hz), which increases upon posture, and
increases even further upon intentional movements, is suggestive
for a Holmes’ (or rubral/midbrain) tremor (Deuschl et al., 1998;
Seidel et al., 2009). Holmes’ tremor is often not as rhythmic as most
other tremor disorders. Holmes tremor is usually caused by a lesion
in the dopaminergic nigrostriatal or cerebello-thalamic pathways,
and often accompanied by other neurological signs. A delay of
4 weeks to even 2 years has been described between the cause of
the lesion (e.g., a cerebrovascular accident) and the occurrence of
Holmes’ tremor (Deuschl et al., 1998).
DOCUMENTATION OF TREMOR
In addition to the standard clinical examination, recording the
drawing of an “Archimedes spiral” and the patients’ handwriting,
can aid in the evaluation of disease progression and therapeutic
response (Elble et al., 1990). Several studies have proven the clinical
use of spiral drawing in ET (Elble et al., 1996; Louis et al., 2012).
One study used spiral analysis to assess tremor severity and spiral
diameter differences in ET and PD (Knoebel and Bain, 2009).
ET patients had significantly severe tremor during spiral drawing,
and PD patients drew spirals with significantly smaller diame-
ters (Knoebel and Bain, 2009). When micrographia is present, the
positive likelihood for PD increases between 2.8 and 5.9 times,
the absence of micrographia gives a negative likelihood range of
0.30–0.44 (Rao et al., 2003). See Figure 1 for an example of the
“Archimedes spiral” in several tremor disorders.
ANCILLARY EXAMINATIONS
The extent to which a patient with tremor undergoes further ancil-
lary examinations depends on the complexity of the case and
whether a diagnosis can be established on patient history and
clinical examination alone. Figure 4 provides an overview of the
diagnostic work-up of a patient with tremor. Most ancillary exam-
inations are directed at differentiating ET from PD, e.g., EMG and
[123I]-FP-CIT single photon emission computerized tomography.
It is recommended to test thyroid function routinely in patients
with action tremor, or if there has been a recent unexplained exac-
erbation of tremor (Bain, 2007). Determining the serum TSH level
is a sensitive and inexpensive marker to exclude tremor caused by
hyperthyroidism (Beckett, 1995). Also, in unexplained tremor in
patients under 55 years of age, Wilson disease should be excluded.
A serum ceruloplasmin level lower than 50 mg/l is strong evidence
for the diagnosis of Wilson disease. Modestly low serum ceru-
loplasmin needs further evaluation. Serum ceruloplasmin within
the normal range does not exclude the diagnosis. Basal 24-h uri-
nary excretion of copper can subsequently be determined if the
diagnosis is uncertain. The 24-h copper excretion is typically
>100 g in symptomatic patients, but finding >40 g may still indi-
cate Wilson disease (Roberts and Schilsky, 2008). When in doubt,
a 24-h urinary copper collection, pre- and post-penicillamine
challenge, should be performed (Bain, 2007). MRI should be per-
formed when Wilson disease is suspected (see Magnetic Resonance
Imaging; Roberts and Schilsky, 2008).
A new and promising method, not further discussed in this
review, for measuring tremor characteristics is currently being
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FIGURE 1 | Spiral drawings of (from left to right) a healthy control, a patient with ET, PD, and cortical tremor.
developed, with the help of in-built accelerometers of mobile
phones. At the moment, the clinical relevance of these mobile
phone applications is being investigated, but preliminary results
are promising for differentiating several tremor disorders (Joundi
et al., 2011; Saifee et al., 2012).
Electromyography
Electromyography is a simple and relatively inexpensive technique
that can be very useful to support or establish a correct diagnosis
(Benaderette et al., 2006). Figure 2 gives an example of an EMG
recording in a patient with cortical tremor and a patient with ET.
Tremor frequency determined by EMG can be a discriminator
when differentiating ET from PD. Both disorders show an overlap
in frequency distributions, particularly in the 5.5–6 Hz range. A
tremor frequency below 5.5 Hz suggests PD; a tremor frequency
above 6 Hz suggests ET (Burne and Boljevac, 2002). A prospec-
tive study by Gironell posed a set of six neurophysiological criteria
for ET which give a sensitivity of 97.7%, a specificity of 82.3%, a
positive predictive value of 95.1% and a negative predictive value
of 91.1% (Gironell et al., 2004), these criteria are summarized in
Table 6. With these criteria, postural tremor in ET could success-
fully be distinguished from postural tremor in PD. Furthermore,
in ET, agonist and antagonist muscles usually show synchronous
activity, while in contrast, tremor in PD is often caused by alternat-
ing contraction of agonist and antagonist muscles (Nistico et al.,
2011). Compared to ET, enhanced physiological tremor typically
shows a higher frequency and shorter burst duration (Milanov,
2001). Milanov (2001) found cerebellar tremor to have a frequency
around 9 Hz during posture and action, decreasing to 6 Hz upon
intention. This contradicts with the frequency range stated by the
Movement Disorders Society, which addresses cerebellar tremor
as mainly intentional tremor below 5 Hz (Deuschl et al., 1998). In
the study by Milanov et al., differentiating cerebellar and enhanced
physiological tremor with solely EMG is challenging. The fre-
quency of cerebellar tremor is generally lower than enhanced
physiological tremor, but more importantly, the bursts are bet-
ter defined in cerebellar tremor. Usually, the maximum amplitude
in cerebellar tremor occurs during intentional movements, while
in enhanced physiological tremor, intention tremor is rarely seen
(Milanov, 2001).
Distinguishing between ET and dystonic tremor can be diffi-
cult. Compared to ET, patients with cervical dystonia and limb
tremor showed greater tremor irregularity (up to 50% more)
measured by cycle-to-cycle variability (Shaikh et al., 2008).
When orthostatic tremor is suspected, EMG is necessary to con-
firm the diagnosis, and shows a typical high-frequency (13–18 Hz)
FIGURE 2 | Bipolar EMG from right first dorsal interosseous (FDI) and
wrist extensors (Extensors) during posture in cortical tremor: high
frequent bursts of <0.05 s (13–18 Hz) and essential tremor: rhythmic
bursts at a frequency of approximately 6 Hz; burst duration is >0.05 s
(figure adapted from van Rootselaar et al., 2006).
Table 6 | Neurophysiological criteria for ET (Gironell et al., 2004).
Neurophysiological criteria for ET
1. Rhythmic burst of postural tremor on EMG
2. Tremor frequency ≥4 Hz
3. Absence of rest tremor, or, if present, frequency 1.5 Hz lower than the
postural tremor
4. Absence of tremor latency from rest to postural position (>2 s)
5. Changes of the dominant frequency peak ≤1 Hz after the weight load
test
6. No changes in tremor amplitude after mental concentration
EMG pattern which appears after a short period of standing
(orthostatism, Figure 3; Yague et al., 2012). Additionally, EMG
signals in orthostatic tremor are highly coherent between left
and right legs, with coherency values of up to 0.99. These high
coherency values are rarely seen in other tremor disorders (Lauk
et al., 1999).
Several tremor disorders show a change in frequency and/or
amplitude upon loading of the stretched limb. In psychogenic
tremor, an increase in amplitude during loading of the limb can
be used to support the diagnosis, but its absence should not be used
to exclude psychogenic tremor (an increase in amplitude of 130%
gives a specificity 92% and a sensitivity of 33%; Schwingenschuh
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FIGURE 3 | Bipolar EMG of a patient with orthostatic tremor from wrist flexors, wrist extensors, tibialis anterior muscle and gastrocnemius muscle
while leaning with both arms against a wall and standing, with a typical frequency of around 14 Hz.
et al., 2011). ET is characterized by a tremor frequency not suscep-
tible to changes upon loading, because of a fixed central oscillating
mechanism. One of the proposed ET neurophysiological criteria
by Gironell et al. (2004) is that the dominant frequency peak may
not decrease by more than 1 Hz after loading. In enhanced phys-
iologic tremor, the tremor frequency peak decreases with more
than 1 Hz or a second tremor frequency peak at a lower frequency
appears upon loading (Deuschl et al., 2001). No study on speci-
ficity and sensitivity for differentiating these patient groups is
published. Elble (2003), however, found 8% of the healthy pop-
ulation to have an EMG pattern that is indistinguishable from
mild ET.
Schwingenschuh et al. propose a set of EMG and accelerometry
markers to be able to establish a positive diagnosis of psychogenic
tremor, instead of a diagnosis of exclusion. A score of 3 or more
suggests psychogenic tremor. Markers included “incorrect tapping
performance at 1, 3, and 5 Hz (maximum three points), entrain-
ment, suppression, or pathological frequency shift at 1, 3, and 5 Hz
(maximum three points), pause or 50% reduction in amplitude of
tremor with ballistic movements (one point), tonic co-activation
before tremor onset (one point), coherence of bilateral tremors
(one point), and increase of tremor amplitude with loading (one
point)” (Schwingenschuh et al., 2011).
Electromyography in familial cortical tremor is used to con-
firm that the tremor is actually myoclonus, and shows periodic,
irregular muscle bursts with a short burst duration of about 50 ms
(van Rootselaar et al., 2005). In the case of suspected neuropathic
tremor, nerve conduction studies should be performed with the
help of EMG (Bain, 2007).
Long-term EMG recording
Using 10-h long continuous EMG recordings, Breit et al. developed
a mathematical equation, based on mean tremor frequency, tremor
occurrence (percentage of segments, in which tremor occurred),
and phase (cross-spectral analysis of extensor and flexor EMG
signals) to be able to differentiate ET from PD (Eq. 1).
F = 20.9− (3.76 ·mean frequency)+ (0.11 · tremor occurence)
− (0.077 · Standard deviation of phase) (1)
Positive values of F predict the diagnosis of PD whereas nega-
tive values predict the diagnosis of ET. This equation was applied
on 13 patients in early stages of the disease, and yielded a 100% fit
between diagnosis predicted by long-term EMG and the diagnoses
inferred by SPECT imaging (Breit et al., 2008).
Coherence analysis (EMG-EEG)
Little is published on the diagnostic value of coherence analysis in
differentiating tremor syndromes. Simultaneous EMG-EEG can
be used to look for cortico-muscular coherences at the tremor fre-
quency. Hellwig et al. (2001) found cortico-muscular coherences
at the tremor frequency in five out of nine arms in patients with
essential tremor and were unable to find this coherence in patients
with enhanced physiological tremor. Van Rootselaar et al. used
coherence analysis to differentiate cortical tremor from essential
tremor. In a group of patients with “Familial Cortical Myoclonic
Tremor with Epilepsy” patients, a strong cortico- and intermus-
cular coherence in the 8- to 30-Hz range was shown with EEG
preceding EMG, this coherence was not found in essential tremor
and healthy controls (van Rootselaar et al., 2006).
Somatosensory evoked potential measurements
Patients with cortical tremor, presenting with tremulous move-
ments, sometimes resembling ET, and with or without a (family)
history of epilepsy, can show a so-called “giant potential” upon
median nerve stimulation during a somatosensory evoked poten-
tial measurement (Okuma et al., 1997; van Rootselaar et al., 2002).
A giant potential is in line with cortical hyperexcitability and a sign
of cortical myoclonus.
[123I]-FP-CIT single photon emission computerized tomography
[123I]-FP-CIT single photon emission computerized tomography,
also called (DAT-) SPECT imaging or FP-CIT-SPECT imaging, can
be used to assess nigrostriatal denervation, a sign of PD (Benamer
et al., 2000). Vlaar et al. (2007) performed a meta-analysis on
the diagnostic accuracy of SPECT imaging in parkinsonian syn-
dromes. They found SPECT imaging with presynaptic tracers
(such as 123I-ioflupane) to be highly accurate to differentiate
between PD and ET (sensitivity 80–100%, specificity 80–100%).
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FIGURE 4 | Diagnostic work-up of a patient with tremor.
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One study showing lowest specificity included not only patients
with ET, but also patients with isolated postural tremor and pos-
tural tremor in combination with rest tremor (Lee et al., 1999).
In a more recent study, Coria et al. also used SPECT to differenti-
ate ET and PD. Only patients with an isolated action tremor were
included, without resting tremor, bradykinesia, or other hypoki-
netic parkinsonian symptoms. They found reduced striatal uptake
in 68.3% of included patients. The odds ratio of finding reduced
striatal uptake was increased three times for patients aged over 50,
and increased five times for patients with an asymmetrical action
tremor (Coria et al., 2012). However, there are also studies that
found reduced striatal uptake in ET compared to controls, but less
severely then PD (Isaias et al., 2008). None of these ET patients
had clinical signs of PD, which makes the clinical use of these
findings questionable. In another study comparing SPECT scans
in parkinsonian syndromes with non-parkinsonian syndromes,
three patients with atypical asymmetrical postural tremor, initially
diagnosed with ET and a fourth patient with a 6-month history
of gait ataxia, slight bradykinesia and rigidity, cerebellar tremor,
and frequent falls, initially diagnosed with cerebellar tremor had
an abnormal SPECT scan. Their diagnosis was altered in sub-
sequently PD and multiple system atrophy. They concluded that
SPECT studies may act as an adjunct to diagnosis (Bairactaris et al.,
2009). One study looked at nine patients referred with suspected
psychogenic parkinsonism. SPECT imaging in this study was suc-
cessful in differentiating pure psychogenic parkinsonism from
psychogenic parkinsonism plus PD, and supported the diagnosis
of underlying PD in five of nine patients (Benaderette et al., 2006).
An Italian cost-effectiveness study showed that using SPECT
imaging for differentiating unclear cases of ET from PD is cost-
effective because of decreasing time on potentially beneficial treat-
ment at a lower overall cost (Antonini et al., 2008). The United
Kingdom National Institute for Health and Clinical Excellence
guideline also suggests the use of SPECT imaging in patients
with tremor where ET cannot be clinically differentiated from PD
(Stewart, 2007). SPECT could be used to avoid the costs of treat-
ing people who do not suffer from PD. However, they also advise
not to use SPECT in all people with PD in place of initial clinical
examination.
In the last decade, SPECT imaging has been used as a surrogate
marker for disease progression. An unexpected consequence of this
was that around 10% of patients, who initially fulfilled the clinical
diagnostic criteria of PD, had normal nigrostriatal uptake (Whone
et al., 2003). These patients have been referred to as “SWEDDs”
(Scans Without Evidence of Dopaminergic Deficit). A study com-
paring clinical and neurophysiological characteristics of SWEDDs
with PD and other tremor disorders by Schwingenschuh et al. sug-
gested that these patients share characteristics with adult-onset
dystonic tremor. Furthermore, these SWEDDs patients did not
show true bradykinesia (with fatiguing and decrement) and did
not respond to levodopa treatment (Schwingenschuh et al., 2010).
Acute levodopa challenge test
Many patients with PD respond to a single dose of levodopa,
and therefore this test is regularly used in clinical practice to dif-
ferentiate ET from PD. Using levodopa response as a diagnostic
test has so far only been studied for differentiating parkinsonian
syndromes. One systematic review that included studies with de
novo PD and well-established PD found acute levodopa treatment
(125–275 mg) to have a positive predictive value of 0.69 (95%
CI 0.59 to 0.90; Clarke and Davies, 2000). The acute levodopa
challenge consisted of a standard dose of 275 mg levodopa plus
decarboxylase inhibitor. Most challenges were performed during
a day admission after domperidone pre-treatment. Response to
chronic levodopa treatment gave a positive predictive value of 0.76
(95% CI 0.70 to 0.82). A chronic levodopa treatment consisted of
a maximum dose of 1000 mg with a duration of treatment varying
from 1 to 6 months (Clarke and Davies, 2000). However, this has
not been assessed for differentiating ET from PD. Also, the effect
of a levodopa trial on tremor has not been assessed separately.
Transcranial sonography
Transcranial sonography can detect increased midbrain echogenic-
ity (Berg et al., 2005). In a study by Bartova, sensitivity and
specificity for transcranial sonography in patients with PD, parkin-
sonian syndromes, ET, and psychogenic movement disorders were
evaluated. Transcranial sonography and SPECT findings corre-
lated in 84% of patients (sensitivity 89.7%, specificity 60% for
transcranial sonography, sensitivity 96.6%, specificity 70% for
SPECT imaging; Bartova et al., 2012). In this study, the diagnostic
accuracy of transcranial sonography was comparable to the more
expensive SPECT imaging. Gaenslen et al. (2008) found a sensi-
tivity of 90.7% and a specificity of 82.4%. Berg et al. performed a
5-year follow up study of PD cases after transcranial sonography.
They found no significant changes in sonography findings across
time. It is suggested that the presence of midbrain hyperechogenic-
ity is a trait rather than a state marker for susceptibility to PD (Berg
et al., 2005). In a study by Berg et al. (1999), 90% of PD patients
exhibited midbrain hyperechogenicity and 8.6% of the healthy
population exhibited the same ultrasound signal, associated in
more than 60% with a functional deficit of the nigrostriatal system
as detected by 18 F-labeled dopa positron emission tomogra-
phy (PET) examinations. Transcranial sonography, although being
much less expensive compared to SPECT imaging, requires high
expertise and is to a certain extent, examiner-dependent. More-
over results need to be further investigated. For these reasons, its
clinical use remains a subject of debate. However, in settings were
SPECT imaging is not available, transcranial sonography can prove
to be useful in unclear cases were PD is suspected and where an
experienced investigator is available.
Magnetic Resonance Imaging
Hyperintensities on T2 MRI in the region of the basal ganglia can
be seen in Wilson disease. According to the American Association
for the Study of Liver Diseases: “MRI should be considered in
Wilson disease prior to treatment in all patients with neurological
symptoms and be part of the evaluation of any patient present-
ing with neurological symptoms consistent with Wilson disease”
(Roberts and Schilsky, 2008).
Fragile X-associated tremor/ataxia syndrome in symptomatic
males shows a characteristic pattern of MRI findings. This pat-
tern includes increased T2 signal intensity in the middle cere-
bellar peduncle and deep white matter of the cerebellum medial,
superior, and inferior to the dentate nuclei (Brunberg et al., 2002).
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In patients with spinocerebellar ataxia, three patterns of
damage can be seen on conventional MRI: spinal atrophy,
olivopontocerebellar atrophy, and cortical cerebellar atrophy
(Mascalchi, 2008). There is even a correlation between the specific
pattern of changes on the MRI and different diseases underlying
the spinocerebellar ataxia (Mascalchi, 2008).
In Holmes’ tremor, data on the relevance of MRI are sparse. In
a case series of 10 patients, the structural lesion was due to hemor-
rhage in six patients and due to cerebral ischemia in four patients.
The thalamus was lesioned in five cases, in other cases, involvement
of the midbrain tegmentum, superior cerebellar peduncle, sub-
stantia nigra, pons, rubro-olivocerebello-rubral loop, rubro-spinal
fibers and nigrostriatal fibers was seen (Gajos et al., 2010).
Olfactory tests
Olfactory dysfunction is found in about 80% of PD cases, regard-
less of disease stage or duration (Doty et al., 1988; Double et al.,
2003). In a study comparing olfactory function of PD with ET
using the University of Pennsylvania Smell Identification Test
(UPSIT), the olfactory function of PD was significantly worse
compared to ET (Shah et al., 2008). Using a cut-off score of 25,
the sensitivity of the UPSIT was 83% and the specificity 94%.
Raising the cut-off score to 30, improves the sensitivity to 97%,
but reduces specificity (87%). In a study comparing olfactory
function in ET with healthy controls, ET patients also showed
significantly lower UPSIT scores (UPSIT for ET 29.0± 6.1 vs.
31.9± 4.6 in controls, p= 0.02), the UPSIT scores were not cor-
related with tremor severity or duration (Louis et al., 2002).
In this study, 27% of ET cases had severe olfactory dysfunc-
tion (UPSIT cut-off score of 25), compared to 2.7% of controls.
At present, olfactory tests can be helpful in the differentiation
between PD and ET, but diagnosis should not rely solely on olfac-
tory function. Therefore the clinical relevance of this test remains
debatable.
CONCLUSION
In most patients, history and clinical examination are sufficient
to establish a correct diagnosis, and further ancillary examina-
tions will not be needed. Investigation should always be guided by
tremor type(s) present and other associated signs and symptoms.
Adherence to the diagnostic work-up provided in Figure 4 will
help the diagnostic process of these patients. However, there are
unclear cases, in which tremor disorders are notoriously difficult
to differentiate. In these unclear cases, there are several techniques,
including neurophysiological techniques and imaging, which can
be useful. Unfortunately,many techniques have not been studied in
large prospective, diagnostic studies to be able to determine impor-
tant variables like sensitivity and specificity, and consequently, the
diagnostic process in this patient group is often based more on
empirical evidence than on quantitative studies.
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